LEILING CHEN: Open Payments
NPI 1174298400 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 10 payments from 8 companies in 2025. Trend: 2023 $59 · 2024 $33 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 1 | $31 |
| Astellas Pharma US Inc | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: QULIPTA, FARXIGA, JARDIANCE, Veozah, Ozempic, OTEZLA, PREVNAR 20, BEXSERO.
Industry payments across VA — which companies pay providers there.
